Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
- Make smarter investment decisions with TipRanks' Smart Investor Picks, delivered to your inbox every week.
Tianda Pharmaceuticals Ltd. ( (HK:0455) ) has issued an update.
Tianda Pharmaceuticals Ltd. has announced its upcoming annual general meeting (AGM) scheduled for June 13, 2025, in Hong Kong. The meeting will address several key agenda items including the review of the company’s financial statements for the year ending December 31, 2024, re-election of directors, re-appointment of auditors, and a resolution to authorize the repurchase of shares. The share repurchase resolution allows the company to buy back up to 10% of its issued shares, which could impact the company’s stock market positioning and shareholder value.
More about Tianda Pharmaceuticals Ltd.
YTD Price Performance: 5.88%
Average Trading Volume: 98,291
Technical Sentiment Signal: Buy
Current Market Cap: HK$387M
For detailed information about 0455 stock, go to TipRanks’ Stock Analysis page.